FY2025 · period end Dec '25 · from the 10-K filed Jan 23, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $35.71B |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0001193125-26-265771 | Jun 10, 2026 | Jun 10, 2026 | Jun 10, 2026 19:54 UTC | EDGAR |
| 8-K | 0001193125-26-219818 | May 7, 2026 | May 12, 2026 | May 12, 2026 21:09 UTC | EDGAR |
| 10-Q | 0001193125-26-190101 | Mar 31, 2026 | Apr 29, 2026 | Apr 29, 2026 15:42 UTC | EDGAR |
| 8-K | 0001193125-26-174940 | Apr 24, 2026 | Apr 24, 2026 | Apr 24, 2026 11:15 UTC | EDGAR |
| 8-K | 0001193125-26-147610 | Apr 8, 2026 | Apr 8, 2026 | Apr 8, 2026 20:05 UTC | EDGAR |
| 8-K | 0001193125-26-101131 | Mar 11, 2026 | Mar 11, 2026 | Mar 11, 2026 12:13 UTC | EDGAR |
| 8-K | 0001193125-26-020133 | Jan 23, 2026 | Jan 23, 2026 | Jan 23, 2026 12:06 UTC | EDGAR |
| 10-K | 0001193125-26-021017 | Dec 31, 2025 | Jan 23, 2026 | Jan 23, 2026 21:01 UTC | EDGAR |
Direct links to SEC EDGAR. SLB has additional filings available on the SEC site.
Figures a later SEC filing revised from what was first reported. Each diff compares the same XBRL tag across two filings — both linked, so you can check it yourself.
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest·FY 2011
Major restatementwas$4.8B
Revised up in a 10-K.
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest·FY 2010
Major restatementwas$4.3B
Revised up in a 10-K.
Net Cash Provided by (Used in) Operating Activities·Q2 2013
Major restatementwas$3.4B
Revised up in a 10-Q. Any P/OCF built on the original was 9.7% too high.
Net Cash Provided by (Used in) Operating Activities·Q3 2013
Major restatementwas$5.9B
Revised up in a 10-Q. Any P/OCF built on the original was 9.6% too high.
Revenues·FY 2011
Notable restatementwas$39.5B
Revised down in a 10-K. Any P/S built on the original was 8.1% too low.
Revenues·Q3 2011
Notable restatementwas$10.2B
Revised down in a 10-Q. Any P/S built on the original was 7.2% too low.
SLB is not the only one.
See every restatement we've found across the market — or get an alert the next time SLB revises a number.
Restatements are detected by comparing every vintage of a fact across all of SLB LIMITED/NV's filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows SLB's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling SLB LIMITED/NV — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on SLB yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on SLB and publish the result to your public profile.
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| $33.13B |
| $28.09B |
| $22.93B |
| Gross Profit | — | — | — | — | — |
|---|
| Operating Income | — | — | $6.52B | $5.01B | $3.37B |
|---|
| Net Income | $3.37B | $4.46B | $4.20B | $3.44B | $1.88B |
|---|
| EPS (Diluted) | $2.35 | $3.11 | $2.91 | $2.39 | $1.32 |
|---|
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $54.87B | $48.94B | $47.96B | $43.13B | $41.51B |
| Total Liabilities | $27.58B | $26.59B | $26.60B | $25.15B | $26.23B |
| Stockholders' Equity | $27.29B | $22.35B | $21.36B | $17.99B | $15.29B |
| Cash & Equivalents | $3.04B | $3.54B | $2.90B | $1.66B | $1.76B |
| Total Debt | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $6.49B | $6.60B | $6.64B | $3.72B | $4.65B |
| Capital Expenditures | $1.69B | $1.93B | $1.94B | $1.62B | $1.14B |
| Free Cash Flow | $4.79B | $4.67B | $4.70B | $2.10B | $3.51B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | — | — | — | — | — |
| Operating Margin | 0.0% | 0.0% | 0.2% | 0.2% | 0.1% |
| Net Margin | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% |
| Return on Equity | 13.6% | 20.4% | 21.4% | 20.7% | 13.5% |
| Return on Assets | 6.5% | 9.2% | 9.2% | 8.1% | 4.5% |
| Debt / Equity | 0.36× | 0.49× | 0.51× | 0.59× | 0.86× |
